Disease Areas
News and analysis on disease research and diagnostics.
The firm said it has secured US Food and Drug Administration breakthrough device designation for its test to classify infections and stratify patients by severe disease risk.
Proteomics International Expects Licensing Deal, Medicare Coverage to Drive PromarkerD Sales in 2024
Premium
The company is making its first major commercial push for its diabetic kidney disease test via a US licensing deal it inked this spring with Sonic Healthcare.
Thermo Fisher Scientific, Pfizer Canada Grant C$300K to Study NGS in Colorectal Cancer Care
The recipients of both grants will study the effects of bringing next-generation sequencing-based testing into a community cancer center.
Quest Diagnostics, Scipher Medicine Collaborate on Rheumatoid Arthritis Test
Quest will provide RNA extraction and sequencing services for Scipher's PrismRA test, a blood-based molecular test for predicting patient response to TNF inhibitors.
Roche Hepatitis B Immunoassay Receives CE Mark
The test can be used as an early marker of acute hepatitis B infection or as an indicator of chronic active hepatitis when combined with other test results and clinical data.